Investors

Investors

CellAED® – Patent Pending

TARGETING SUDDEN CARDIAC ARREST (SCA)
Series A Investment Opportunity

Product

  • Medical Technology play
  • World’s first mobile phone Defibrillator (AED) & Hi-Tech Phone Case
  • Solves the SCA Survival Gap
  • Patented designs and comprehensive IP strategy
  • New materials and electrical components technology
  • Clinical Trial stage ready Prototypes
  • Multiple product & industry applications
  • Biometric Data mining capacity to reduce Health Sector costs

Company & Management

  • Experienced Board & Executives focused on Commercialisation & transaction ready Strategy
  • Global Manufacturing & Distribution partnerships developing
  • Experienced international advisory & technical team

Market Size

  • Substantial barriers to entry
  • Significant global demand expected
  • Mobile Accessory and AED markets projected to grow to $100b

Return on Investment 

  • Significant Seed Investment to date
  • Series A Investment on modest valuation
  • Open for up to 45% equity stake
  • Liquidity through IPO within 3 Years after Series A
  • Liquidity possibility via Series B Data Licensing deal
  • Projected 10x multiples of investment

Should this meet your investment criteria, please contact us for a copy of the Investment Memorandum. We will be in touch by phone for a confidential discussion about your interest.